Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
4335 participants
OBSERVATIONAL
2016-11-30
2020-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
CHAIN is a multi-centre cohort study with a nested case control analysis of stored biological samples. Study sites are located in Africa and South Asia. Children will be recruited at admission to hospital, stratified by nutritional status. Exposures will be assessed at admission, during hospitalisation, at discharge, and at two time points after discharge. The main outcomes of interest are mortality, re-admission to hospital and failure of nutritional recovery up to 180 days after discharge. To determine community health norms, an additional sample of children living in the same communities will be enrolled and assessed at one time point only.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
First Line Antimicrobials in Children With Complicated Severe Acute Malnutrition
NCT03174236
Optimising Antibiotic Treatment for Sick Malnourished Children
NCT02746276
Trial in Childhood Pneumonia With Malnutrition
NCT00968370
Improving Care Through Azithromycin Research for Infants in Africa
NCT04235816
Azithromycin for Uncomplicated Severe Acute Malnutrition in Burkina Faso (Pilot)
NCT03568643
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
CHAIN's initial aim is to better understand the characteristics that determine increased risk of mortality in this vulnerable population, whether biological (related to infection, immunity and metabolism), nutritional (intake and anthropometry), health system factors (affecting management and discharge) or behavioural (community/caregiver interactions). CHAIN brings clinicians and scientists together from a variety of high-burden settings in Africa and South Asia. CHAIN will establish prospective cohorts of acutely ill young children across different geographies with differing population, social and environmental characteristics (stunted vs. wasting, rural vs. urban and presence of risk factors such as malaria and HIV).
Eight sites will be involved, including three hospitals in Kenya (Kilifi County, Migori County and Mbagathi District), two in Bangladesh (Matlab and the icddr,b Dhaka), and one in each of Uganda (Mulago), Malawi (Queen Elizabeth Community Hospital), Pakistan (Civil Hospital Karachi) and in West Africa (TBA). Site will enroll children at admission to hospital, and assess their clinical, social and economic status at admission, during hospitalisation, at discharge and during follow up for 180 days after discharge. The sites will also enrol children from the community to determine community norms (where ill and undernourished children would be expected to typically recover to). Protocols and procedures will be carefully harmonised across sites.
Children aged 2 months to 2 years admitted to hospital will be considered for inclusion and enrolment stratified by nutritional status. Following informed consent, baseline data of prognostic importance, including demographic and social information, a detailed clinical examination, anthropometry and measurement of vital signs, including pulse oximetry, will be collected using a standard proforma. A research blood sample will be collected together with the routine clinical blood draw to minimize the patient's discomfort. Rectal swabs and faecal sample will also be obtained from all children.
During admission, care will be provided according to WHO and national guidelines. Children will be reviewed daily and clinical features, progress and treatment received recorded on a structured case report form. In the event of death in hospital, a standard audit questionnaire will be completed. During admission, primary caregivers, usually the mother, will be interviewed screened for mental health problems. At discharge, anthropometry, a clinical assessment and blood, rectal swab and whole stool collected. Families will be linked with chronic care services where needed.
A home visit will be conducted for all participants, the GPS location recorded. Information homestead infrastructure, water and sanitation, population, livelihood, child care and socioeconomic characteristics. Children will be followed up at 45, 90 and 180 days after discharge. A health questionnaire will document health and social events, and dietary intake. Anthropometry, and faecal and blood samples collected.
Caregivers will be asked to attend the study hospital should the caregiver believes they may require hospitalisation. Study participants who are re-admitted to hospital will undergo standardised clinical assessment including history, examination and sample collection. In the event of death occurring outside the study hospital, a standard verbal autopsy (VA) will be completed by trained staff within 28 days of becoming aware of a death. VAs along with all available information will be used to ascribe causes of death.
Community participants will be invited to the study clinic for assessment. Following informed consent, they will have a clinical examination, anthropometry, blood and stool samples as children who are admitted. Children requiring non-urgent medical care will be eligible for inclusion as community participants but will be given basic treatment in the study clinic and/or referred to appropriate treatment centres. Study staff will refer community participants with incomplete vaccination or requiring care for chronic conditions as needed.
Several domains of exposure will be assessed: demographic, nutrition and metabolism; acute and chronic conditions; community-acquired and nosocomial infections (including antimicrobial resistance); gut function \& dysbiosis; inflammation; responses to treatment; and the home care environment.
Successful design of an intervention package to address post-discharge child mortality will require attention social and economic agency and vulnerability, access and interactions with health services, and ethical considerations. A qualitative sub-study will examine these factors in context in rural and urban sites in Kenya and Bangladesh to identify critical social limitations and potential approaches to intervention. These data will inform the network's development, piloting, and implementation of interventions.
Additional sub-studies at a subset of sites will also examine in more detail the diagnosis and role of TB; and changes in functional immune responses; body composition and neurodevelopment during follow up.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hospitalized children with severe wasting or kwashiorkor (SWK)
Children recruited at admission to hospital and followed up for 180 days post-discharge.
No interventions assigned to this group
Community reference participants (CP)
Children recruited from the community who are seen a single appointment in the community.
No interventions assigned to this group
Hospitalized children with moderate wasting (MW)
Children recruited at admission to hospital and followed up for 180 days post-discharge.
No interventions assigned to this group
Hospitalized children without wasting (NW)
Children recruited at admission to hospital and followed up for 180 days post-discharge.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Admitted to hospital.
* Planning to remain within the hospital catchment area and willing to come for specified visits during the 6 month follow up period.
* Parent or guardian consents on child's behalf.
* Aged 2 to 23 months
* Living in the same community as the acutely ill children recruited.
* Not having an acute illness requiring hospital admission
* Absence of known, but untreated HIV or TB
* Not admitted to hospital within the last 14 days
* Not previously included in the study
* Parent or guardian consents on child's behalf.
Exclusion Criteria
* Unable to tolerate oral feeds while in his/her usual state of health
* Underlying terminal illness that in the opinion of the treating physician is likely to lead to death within 6 months (e.g., cancer, congenital heart disease)
* Diagnosed with a condition that in the opinion of the treating physician is likely to require surgery within 6 months
* Diagnosed chromosomal abnormality (syndromically or genetically diagnosed abnormality)
* Primary reason for admission is poisoning, trauma or a surgical condition
* Previously enrolled in this study
* Sibling currently or previously enrolled in this study
(\* children requiring resuscitation will be defined as those with on-going cardiac or pulmonary arrest or judged to be peri-arrest by the attending physician)
2 Months
23 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Washington
OTHER
Kenya Medical Research Institute
OTHER
KEMRI-Wellcome Trust Collaborative Research Program
OTHER
Makerere University
OTHER
Oregon Health and Science University
OTHER
The Hospital for Sick Children
OTHER
University of Amsterdam
OTHER
University of Malawi
OTHER
Aga Khan University
OTHER
International Centre for Diarrhoeal Disease Research, Bangladesh
OTHER
University of Oxford
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
James A Berkley, MBBS, FRCPCH
Role: PRINCIPAL_INVESTIGATOR
University of Oxford
Judd L Wilson, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
University of Washington
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Matlab Hospital
Dhaka, Chittagong, Bangladesh
ICDDR,B Dhaka Hospital
Dhaka, , Bangladesh
Kilifi County Hospital
Kilifi, , Kenya
Migori County Hospital
Migori, , Kenya
Mbagathi District Hospital
Nairobi, , Kenya
Queen Elizabeth Central Hospital
Blantyre, , Malawi
Civil Hospital Karachi
Karachi, , Pakistan
Mulago Hospital
Kampala, , Uganda
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Njunge JM, Tickell K, Diallo AH, Sayeem Bin Shahid ASM, Gazi MA, Saleem A, Kazi Z, Ali S, Tigoi C, Mupere E, Lancioni CL, Yoshioka E, Chisti MJ, Mburu M, Ngari M, Ngao N, Gichuki B, Omer E, Gumbi W, Singa B, Bandsma R, Ahmed T, Voskuijl W, Williams TN, Macharia A, Makale J, Mitchel A, Williams J, Gogain J, Janjic N, Mandal R, Wishart DS, Wu H, Xia L, Routledge M, Gong YY, Espinosa C, Aghaeepour N, Liu J, Houpt E, Lawley TD, Browne H, Shao Y, Rwigi D, Kariuki K, Kaburu T, Uhlig HH, Gartner L, Jones K, Koulman A, Walson J, Berkley J. The Childhood Acute Illness and Nutrition (CHAIN) network nested case-cohort study protocol: a multi-omics approach to understanding mortality among children in sub-Saharan Africa and South Asia. Gates Open Res. 2022 Nov 3;6:77. doi: 10.12688/gatesopenres.13635.2. eCollection 2022.
Tickell KD, Denno DM, Saleem A, Ali A, Kazi Z, Singa BO, Otieno C, Mutinda C, Ochuodho V, Richardson BA, Asbjornsdottir KH, Hawes SE, Berkley JA, Walson JL. Enteric Permeability, Systemic Inflammation, and Post-Discharge Growth Among a Cohort of Hospitalized Children in Kenya and Pakistan. J Pediatr Gastroenterol Nutr. 2022 Dec 1;75(6):768-774. doi: 10.1097/MPG.0000000000003619. Epub 2022 Sep 20.
Childhood Acute Illness and Nutrition Network. Childhood Acute Illness and Nutrition (CHAIN) Network: a protocol for a multi-site prospective cohort study to identify modifiable risk factors for mortality among acutely ill children in Africa and Asia. BMJ Open. 2019 May 5;9(5):e028454. doi: 10.1136/bmjopen-2018-028454.
Related Links
Access external resources that provide additional context or updates about the study.
The CHAIN Network
Childhood Acute Illness and Nutrition (CHAIN) Network: a protocol for a multi-site prospective cohort study to identify modifiable risk factors for mortality among acutely ill children in Africa and Asia
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OPP1131320
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.